+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog



Comparability of the electrophysiologic responses and plasma and myocardial tissue concentrations of sotalol and its d stereoisomer in the dog



Journal of Cardiovascular Pharmacology 16(2): 204-211



The relative plasma, myocardial, and skeletal muscle concentrations as well as activities of racemic and d-sotalol were assessed in both anesthetized and conscious dogs. In acute anesthetized experiments, the agents were infused i.v. over a 15-min interval at doses of 1 and 4 mg/kg. Arterial blood samples and punch biopsy specimens from the left ventricular myocardium and skeletal muscle (gastrocnemius) were taken at the completion of each infusion and at periodic intervals for the ensuing 3 h. The drugs were also administered over a 2-week dosing interval to conscious dogs at a dose of 5 mg/kg given twice daily. ECG alterations and venous blood samples were withdrawn on the 1st, 3rd, 7th and 14th day of drug administration. Myocardial and skeletal muscle samples were taken at killing on day 14. In anesthetized dogs, both forms of sotalol decreased heart rate, lowered arterial pressure, prolonged ventricular refractoriness, and caused measurable increases in the PR, QT, and QTc intervals in the absence of any effect on QRS duration. Similar effects on heart rate and QTc and lack of influence on the PR and QRS interval were observed in conscious animals. Tissue drug concentrations were closely correlated with plasma drug levels. Comparable mean steady-state tissue/plasma ratios of 2.26-2.94 were attained immediately following acute i.v. drug infusions. These were larger than those observed following chronic oral drug administration for 14 days. The data, however, clearly demonstrated the equivalence of the plasma and myocardial drug levels obtained in dogs following i.v. infusion of 1 mg/kg or oral administration of 5 mg/kg of dl- or d-sotalol.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039614278

Download citation: RISBibTeXText

PMID: 1697375


Related references

Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations. British Medical Journal 290(6484): 1784-1785, 1985

Electrophysiologic effects of bretylium and sotalol on acute myocardial ischemia in the dogs. Japanese Circulation Journal 49(8): 915, 1985

D sotalol electrophysiologic properties in relation to dose and to plasma concentration. American Heart Association Monograph (114): III-169, 1985

Cellular electrophysiologic responses of isolated neonatal and adult cardiac fibers to d-sotalol. Journal of the American College of Cardiology 11(5): 1094-1099, 1988

Short-term myocardial uptake of d- and l-sotalol in humans: relation to hemodynamic and electrophysiologic effects. Journal of Cardiovascular Pharmacology 31(6): 876-884, 1998

Electrophysiologic properties of sotalol and d-sotalol. A current view. European Heart Journal 14 Suppl H: 24-29, 1993

The effects of propranolol and sotalol on the electrophysiologic and enzymatic impact of myocardial ischemia induced in vitro in the guinea pig heart. Journal de Pharmacologie 15(3): 331-351, 1984

Comparison of the electrophysiologic properties of d sotalol and dl sotalol in man. Journal of the American College of Cardiology 5(2 Part 2): 438, 1985

Hydrolysis and binding of a toxic stereoisomer of soman in plasma and tissue homogenates from rat, guinea pig and marmoset, and in human plasma. Biochemical Pharmacology. 46(8): 1413-1419, 1993

Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis. Alimentary Pharmacology & Therapeutics 13(11): 1451-1458, 1999

Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates: Z,E/E,E stereoisomer ratios. Chemical Research in Toxicology 23(5): 986-995, 2010

Comparability of whole-blood and plasma clozapine and norclozapine concentrations. British Journal of Clinical Pharmacology 56(1): 135-138, 2003

Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs. Journal of Pharmacology and Experimental Therapeutics 214(2): 449-453, 1980

Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity. Journal of Cardiovascular Pharmacology 1(5): 541-550, 1979

Plasma Concentrations and Haemodynamic Effects of d-Sotalol after β-Blockade in Dogs. Basic & Clinical Pharmacology & Toxicology 67(5): 420-425, 1990